154 related articles for article (PubMed ID: 38370411)
1. Case report: From palliative to potentially curative - the advent of immunotherapy providing hope to advanced gallbladder adenocarcinoma.
Leong EKF; Tan NCH; Pang NQ; Kow AWC
Front Immunol; 2024; 15():1353430. PubMed ID: 38370411
[TBL] [Abstract][Full Text] [Related]
2. [Conversion Surgery Following Systemic Chemotherapy for Advanced Gallbladder Cancer with Peritoneal Dissemination-A Case Report].
Okawa K; Sakai N; Takayashiki T; Kuboki S; Takano S; Suzuki D; Hosokawa I; Mishima T; Konishi T; Nishino H; Nakada S; Otsuka M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1962-1964. PubMed ID: 38303265
[TBL] [Abstract][Full Text] [Related]
3. Durvalumab: A Review in Advanced Biliary Tract Cancer.
Fung S; Syed YY
Target Oncol; 2023 Nov; 18(6):965-972. PubMed ID: 37943483
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study.
Oh DY; Lee KH; Lee DW; Yoon J; Kim TY; Bang JH; Nam AR; Oh KS; Kim JM; Lee Y; Guthrie V; McCoon P; Li W; Wu S; Zhang Q; Rebelatto MC; Kim JW
Lancet Gastroenterol Hepatol; 2022 Jun; 7(6):522-532. PubMed ID: 35278356
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) - a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial.
Goetze TO; Bechstein WO; Bankstahl US; Keck T; Königsrainer A; Lang SA; Pauligk C; Piso P; Vogel A; Al-Batran SE
BMC Cancer; 2020 Feb; 20(1):122. PubMed ID: 32059704
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Conversion Surgery Following Chemotherapy in Initially Unresectable Locally Advanced Gallbladder Carcinoma].
Hashimoto Y; Ueno K; Akita M; Tsugawa D; Awazu M; Mukubou H; Komatsu S; Terai S; Tanaka M; Kido M; Toyama H; Ajiki T; Fukumoto T
Gan To Kagaku Ryoho; 2019 Apr; 46(4):775-777. PubMed ID: 31164532
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
8. Locally advanced gallbladder cancer treated with effective chemotherapy and subsequent curative resection: a case report.
Inoue M; Hakoda K; Sawada H; Hotta R; Ohmori I; Miyamoto K; Toyota K; Sadamoto S; Takahashi T
J Med Case Rep; 2022 Jan; 16(1):30. PubMed ID: 35039070
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival after multidisciplinary therapy for residual gallbladder cancer with peritoneal dissemination: a case report.
Kuga D; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
Surg Case Rep; 2017 Dec; 3(1):76. PubMed ID: 28616794
[TBL] [Abstract][Full Text] [Related]
10. A case from the future of HPB surgical oncology: resection of biliary tract cancer after immunotherapy.
Satyananda V; Chouliaras K; Cherkassky L; Schwarz RE
J Surg Case Rep; 2021 Oct; 2021(10):rjab414. PubMed ID: 34729163
[TBL] [Abstract][Full Text] [Related]
11. Port site metastases a year after initial laparoscopic cholecystectomy. Should the use of retrieval bags during laparoscopic cholecystectomy be the new gold standard?
Petryshyn N; Dražić T; Hogendorf P; Strzelczyk J; Strzałka A; Szwedziak K; Durczyński A
Pol Przegl Chir; 2021 May; 93(6):61-65. PubMed ID: 36169533
[TBL] [Abstract][Full Text] [Related]
12. Conversion surgery following gemcitabine plus cisplatin therapy for initially unresectable gallbladder cancer with peritoneal carcinomatosis: a case report.
Wakasa Y; Toyoki Y; Kusumi T; Kameyama Y; Odagiri T; Jin H; Nakai M; Aoki K; Kawashima H; Endo M
Surg Case Rep; 2022 Mar; 8(1):50. PubMed ID: 35332404
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial.
Stein A; Arnold D; Bridgewater J; Goldstein D; Jensen LH; Klümpen HJ; Lohse AW; Nashan B; Primrose J; Schrum S; Shannon J; Vettorazzi E; Wege H
BMC Cancer; 2015 Jul; 15():564. PubMed ID: 26228433
[TBL] [Abstract][Full Text] [Related]
14. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study.
Kato A; Shimizu H; Ohtsuka M; Yoshidome H; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Kimura F; Miyazaki M
Ann Surg Oncol; 2013 Jan; 20(1):318-24. PubMed ID: 23149849
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of combination chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced cancers of the bile duct, gallbladder, and ampulla of Vater.
Sohn BS; Yuh YJ; Kim KH; Jeon TJ; Kim NS; Kim SR
Tumori; 2013; 99(2):139-44. PubMed ID: 23748804
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder.
Malik IA; Aziz Z; Zaidi SH; Sethuraman G
Am J Clin Oncol; 2003 Apr; 26(2):174-7. PubMed ID: 12714891
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial.
Shroff RT; Javle MM; Xiao L; Kaseb AO; Varadhachary GR; Wolff RA; Raghav KPS; Iwasaki M; Masci P; Ramanathan RK; Ahn DH; Bekaii-Saab TS; Borad MJ
JAMA Oncol; 2019 Jun; 5(6):824-830. PubMed ID: 30998813
[TBL] [Abstract][Full Text] [Related]
18. [Successful curative resection after chemotherapy for initially unresectable advanced gallbladder cancer with rectal metastasis:a case report].
Inoue H; Toma A; Watanabe N; Ito H; Ochiai T; Otsuji E
Nihon Shokakibyo Gakkai Zasshi; 2018; 115(10):905-913. PubMed ID: 30305572
[TBL] [Abstract][Full Text] [Related]
19. A feasibility study of gemcitabine, S-1 and leucovorin combination therapy (GSL) for advanced biliary tract cancer.
Takahara N; Isayama H; Nakai Y; Sasaki T; Saito K; Sato T; Hakuta R; Ishigaki K; Saito T; Hamada T; Mizuno S; Kogure H; Tada M; Koike K
J Chemother; 2019 Sep; 31(5):284-289. PubMed ID: 31179889
[No Abstract] [Full Text] [Related]
20. Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer.
Meyerhardt JA; Zhu AX; Stuart K; Ryan DP; Blaszkowsky L; Lehman N; Earle CC; Kulke MH; Bhargava P; Fuchs CS
Dig Dis Sci; 2008 Feb; 53(2):564-70. PubMed ID: 17597402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
